As of March 31, 2026, Maitreya Medicare Limited carries a market capitalization of 1.21B, placing it among publicly traded companies globally. Its enterprise value stands at 1.36B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.21B |
| Enterprise Value | 1.36B |
As of March 31, 2026, Maitreya Medicare Limited has 6.78M shares outstanding.
| Shares Outstanding | 6.78M |
These figures are as of March 31, 2026.
| PB Ratio | 4.17 |
| P/TBV Ratio | 4.17 |
As of March 31, 2026, Maitreya Medicare Limited maintains a current ratio of 1.47, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.47 |
| Quick Ratio | 0.55 |
| Debt / Equity | 77.64 |
As of the close on October 22, 2026, Maitreya Medicare Limited's stock has declined approximately 45.63% over the past 52 weeks. The 50-day moving average sits at 118.32, while the 200-day moving average is 168.82.
| 52-Week Price Change | -45.63% |
| 50-Day Moving Average | 118.32 |
| 200-Day Moving Average | 168.82 |
As of March 31, 2026, Maitreya Medicare Limited holds 87.22M in cash and equivalents against 231.18M in total debt, resulting in a net debt position of 144.49M. Total book value stands at 290.30M, with working capital of 74.52M providing operational flexibility.
| Cash & Cash Equivalents | 87.22M |
| Total Debt | 231.18M |
| Net Debt | 144.49M |
| Equity (Book Value) | 290.30M |
| Book Value Per Share | 42.84 |
| Working Capital | 74.52M |
Already premium?